Clinical trial
Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease
NCT00393250 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00393250 |
|---|---|
| Title | Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease |
| Official title | Hypnosis as a Pain and Symptom Management Strategy in Patients With Sickle Cell Disease |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Pain Management |
| Intervention type | Other |
| Interventions | Hypnosis, Control |
| Enrollment | 31 |
| Start date | Apr 30, 2007 |
| Primary completion | Jun 4, 2012 |
| Completion | Jun 4, 2012 |
| First posted | Oct 27, 2006 |
| Last update posted | Oct 29, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: